BioWorld

July 15, 2005

View Archived Issues

PPD's Stock Rises On Takeda Deal, Better 2005 EPS Forecast

Read More

Diagnostics & Imaging Book

Read More

Other News To Note

Read More

Genzyme Beats Estimates; Revenues Jump 22 Percent

Growing product sales and an expanding pipeline led Genzyme Corp. to report solid earnings for the second quarter, once again beating consensus estimates. (BioWorld Today) Read More

BioMarin Offering To Raise $60M For Enzyme Therapies

Read More